Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing
Open Access
- 31 July 2021
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 11 (8) , 1025
Abstract
Background: Various three-dimensional (3D) glioblastoma cell culture models have a limited duration of viability. Our aim was to develop a long-term 3D glioblastoma model, which is necessary for reliable drug response studies. Methods: Human U87 glioblastoma cells were cultured in alginate microfibers for 28 days. Cell growth, viability, morphology, and aggregation in 3D culture were monitored by fluorescent and confocal microscopy upon calcein-AM/propidium iodide (CAM/PI) staining every seven days. The glioblastoma 3D model was validated using temozolomide (TMZ) treatments 3 days in a row with a recovery period. Cell viability by MTT and resistance-related gene expression (MGMT and ABCB1) by qPCR were assessed after 28 days. The same TMZ treatment schedule was applied in 2D U87 cell culture for comparison purposes. Results: Within a long-term 3D model system in alginate fibers, U87 cells remained viable for up to 28 days. On day 7, cells formed visible aggregates oriented to the microfiber periphery. TMZ treatment reduced cell growth but increased drug resistance-related gene expression. The latter effect was more pronounced in 3D compared to 2D cell culture. Conclusion: Herein, we described a long-term glioblastoma 3D model system that could be particularly helpful for drug testing and treatment optimization.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (451-03-9/2021-14/200007, 451-03-9/2021-14/200135, 451-03-9/2021-14/200287)
- European Commission (952033)
This publication has 36 references indexed in Scilit:
- Controlling Shear Stress in 3D Bioprinting is a Key Factor to Balance Printing Resolution and Stem Cell IntegrityAdvanced Healthcare Materials, 2015
- Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cellsCancer Letters, 2015
- Cancer stem cell marker‐expressing cell‐rich spheroid fabrication from PANC ‐1 cells using alginate microcapsules with spherical cavities templated by gelatin microparticlesBiotechnology Progress, 2015
- Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsulesBiomaterials, 2014
- The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancerAdvanced Drug Delivery Reviews, 2014
- Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECMBiomaterials, 2013
- Alginate: Properties and biomedical applicationsProgress in Polymer Science, 2012
- Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human GliomaJournal of Neuro-Oncology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001